MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

Abstract Background Mid-regional pro-atrial natriuretic peptide (MR-proANP) is a useful biomarker in outpatients with type 2 diabetes (T2D) to diagnose heart failure (HF). Elevated B-type natriuretic peptides are included in the definition of HF with preserved ejection fraction (HFpEF) but little is...

Full description

Bibliographic Details
Main Authors: Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W. Hansen, Magnus T. Jensen, Henrik U. Andersen, Peter Rossing, Tina Vilsbøll, Peter G. Jørgensen
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular disease
Diabetes complications
Macrovascular disease
Type 2 diabetes
MR-proANP
Heart failure
Online Access:http://link.springer.com/article/10.1186/s12933-020-01155-9

Internet

http://link.springer.com/article/10.1186/s12933-020-01155-9

Similar Items